Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 52 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 10117907

    Glycosylated PACAP/VIP analogues with enhanced CNS penetration for treatment of neurodegenerative diseases

    Arizona Board of Regents on Behalf of the University of Arizona, a body corporate · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  2. US 10113151

    Composition of viral vectors in lecithin liposomes, preparation method and treatment methods

    The Regents of the University of California · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  3. US 10111878

    N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer

    Agios Pharmaceuticals, Inc. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  4. US 10113183

    Adeno-associated virus vectors for treatment of glycogen storage disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  5. US 10111861

    Treatment of breast cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  6. US 10111862

    Traps in the treatment of macular degeneration

    Aldeyra Therapeutics, Inc. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  7. US 10111865

    Methods of sedation during critical care treatment

    OVID THERAPEUTICS INC. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  8. US 10105341

    Treatment for obesity

    Jazz Pharmaceuticals International III Limited · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  9. US 10105436

    Smallpox vaccine for cancer treatment

    Calidi Biotherapeutics, Inc. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  10. US 10100049

    JAK kinase inhibitor compounds for treatment of respiratory disease

    Theravance Biopharma R&D IP, LLC · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  11. US 10100020

    Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases

    United Kingdom Research and Innovation · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  12. US 10098925

    Protein SLURP-1 for use in the treatment of ocular diseases

    Brightpulse Holding Ltd. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  13. US 10093745

    Anti-CSPG4 fusions with interferon for the treatment of malignancy

    The Regents of the University of California · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  14. US 10093664

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  15. US 10092596

    Tungstate treatment of the dysbiosis associated with gastrointestinal inflammation

    The Regents of the University of California · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  16. US 10092580

    Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  17. US 10087444

    MicroRNA composition for the treatment of neuroblastoma

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  18. US 10085951

    Curcuminoid formulations and related methods of treatment

    DESIGNS FOR HEALTH, INC. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  19. US 10080749

    Multi-drug therapies for tuberculosis treatment

    The Regents of the University of California · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  20. US 10080730

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    United Therapeutics Corporation · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  21. US 10076520

    Use of tyrosine kinase inhibitor in cancer treatment

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  22. US 10077296

    Methods and compositions for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  23. US 10071083

    Use of gaboxadol in the treatment of tinnitus

    OVID THERAPEUTICS INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  24. US 10071095

    1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders

    Addex Pharma, S.A. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.